Huang et al. identified that the expression of FXR was associated with a high diagnostic accuracy in the early stage (stage I) of ccRCC, and moreover, genetic mutations, as well as the DNA methylation of FXR, were significantly linked to a prognosis in ccRCC patients [135]. Here, NR1H4 is linked to nonpapillary renal cell carcinoma.